Expert review of pharmacoeconomics & outcomes research.

ISSN 1473-7167Taylor and Francis Ltd.United Kingdom
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Journal identity
Titles
Expert Review of Pharmacoeconomics and Outcomes Research
Expert Rev. Pharmacoecon. Outcomes Res. (abbreviated)
Expert Review of Pharmacoeconomics & Outcomes Research TAYLOR & FRANCIS LTD
Expert review of pharmacoeconomics & outcomes research.
Expert Rev Pharmacoecon Outcomes Res (abbreviated)
Key identifiers
ISSN
1473-7167
1473-7167
eISSN
1744-8379
NLM ID
101132257
Publisher / basic metadata
Publisher
Taylor and Francis Ltd.
London : Future Drugs Ltd, [2001-
Country
Language
English
ENG

Indexing & coverage

Current indexing summary
Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
2001–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCNot found in this source

Metrics

MetricYearValueQuartileRankSource
JIF20251.5Q310681JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.511
Best Quartile
Q3
H-index
69
Subject categories
  • Health Policy — Q3
  • Medicine (miscellaneous) — Q3
  • Pharmacology (medical) — Q3
More metrics
Coverage
2001–2026
Country
United Kingdom
Region
Western Europe
Publisher
Taylor and Francis Ltd.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
151
Total documents (3 years)
356
Total references
6844
Total citations (3 years)
734
Citable documents (3 years)
321
Citations per document (2 years)
2.19
References per document
45.32
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1473-7167, 1744-8379
SCImago Source ID
21371
SCImago Rank (across all SCImago source types)
11654

Publication activity

Publication activity
SCImago
2025
151 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subjects / categories
Subject area (SCImago)
MeSH (PubMed)
Cost-Benefit Analysis.; Decision Making; Drug Therapy/economics; Economics, Pharmaceutical; Outcome Assessment, Health Care
Coverage / history
Scopus:2001-2026
MEDLINE:MEDLINE: v9n1, Feb. 2009-In: PubMed: v9n1, Feb. 2009-;
PubMed:MEDLINE: v9n1, Feb. 2009-In: PubMed: v9n1, Feb. 2009-;